- Home
- WAFD vs HCM Comparison
WAFD vs HCM Comparison
Compare WAFD & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WAFD | HCM |
|---|---|---|
| Founded | 1917 | 2000 |
| Country | United States | Hong Kong |
| Employees | 2037 | 1796 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WAFD | HCM |
|---|---|---|
| Price | $34.92 | $11.99 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 4 | 1 |
| Target Price | ★ $35.00 | $13.75 |
| AVG Volume (30 Days) | ★ 529.5K | 27.2K |
| Earning Date | 04-16-2026 | 03-05-2026 |
| Dividend Yield | ★ 3.08% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.60 |
| Revenue Next Year | $4.15 | $15.62 |
| P/E Ratio | $11.49 | ★ $5.49 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.31 | $11.83 |
| 52 Week High | $38.59 | $19.50 |
Technical Indicators
Market Signals| Indicator | WAFD | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 55.04 | 23.81 |
| Support Level | $34.00 | N/A |
| Resistance Level | $36.02 | $15.75 |
| Average True Range (ATR) | 0.98 | 0.34 |
| MACD | -0.19 | -0.11 |
| Stochastic Oscillator | 21.35 | 11.43 |
Price Performance
Historical ComparisonAbout WAFD WaFd Inc.
WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.